Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment
Jill K. Wieser, MD,
Gina J. Kuehn, MD,
James C. Prezzano, MD,
Elizabeth H. Cusick, MD,
Julia D. Stiegler, MD,
Glynis A. Scott, MD,
Jane L. Liesveld, MD,
Lisa A. Beck, MD
Affiliations
Jill K. Wieser, MD
Department of Dermatology, University of Rochester Medical Center, Rochester, New York; Correspondence to: Jill K. Wieser, MD, URMC, Department of Dermatology, 40 Celebration Dr, Rochester, NY 14642.
Gina J. Kuehn, MD
Department of Dermatology, University of Rochester Medical Center, Rochester, New York
James C. Prezzano, MD
Department of Dermatology, University of Rochester Medical Center, Rochester, New York
Elizabeth H. Cusick, MD
Department of Dermatology, University of Rochester Medical Center, Rochester, New York
Julia D. Stiegler, MD
Department of Dermatology, University of Rochester Medical Center, Rochester, New York
Glynis A. Scott, MD
Department of Dermatology, University of Rochester Medical Center, Rochester, New York
Jane L. Liesveld, MD
Department of Medicine–Hematology/Oncology, University of Rochester Medical Center, Rochester, New York
Lisa A. Beck, MD
Department of Dermatology, University of Rochester Medical Center, Rochester, New York
